戻る
CARsgen Therapeutics Holdings Limited (02171.HK)価格
02171.HK 株価推移チャート
CARSGEN-B (02171.HK)
CARsgen Therapeutics Holdings Limited
HK$16.19
-1.22%
$-0.19
休場: Jan 16, 16:00:00 HKT
データなしFollow-Up Questions
CARsgen Therapeutics Holdings Limitedの主要な財務諸表は何ですか？
02171.HKの主要な財務比率は何ですか？
CARsgen Therapeutics Holdings Limitedの収益はセグメントまたは地域別にどのように分けられていますか？
CARsgen Therapeutics Holdings Limitedは収益を上げていますか？
CARsgen Therapeutics Holdings Limitedに負債はありますか？
CARsgen Therapeutics Holdings Limitedの発行済株式数は何株ですか？
主要データ
前終値
$16.39
始値
$16.39
当日レンジ
$15.87 - $16.6
52週レンジ
$8.5 - $25.6
取引高
1.3M
平均取引高
1.7M
1株当たり利益(TTM)
-1.06
配当利回り
--
時価総額
$8.8B
CARSGEN-Bとは何ですか？
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 371 full-time employees. The company went IPO on 2021-06-18. The Company’s main business is engaged in developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The firm conducts its business in the domestic and overseas markets.